Last reviewed · How we verify
Henogen HBV vaccine
Henogen HBV vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus antigens.
Henogen HBV vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus antigens. Used for Prevention of hepatitis B virus infection.
At a glance
| Generic name | Henogen HBV vaccine |
|---|---|
| Sponsor | Henogen |
| Drug class | Vaccine |
| Target | Hepatitis B surface antigen (HBsAg) |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
The vaccine contains hepatitis B surface antigen (HBsAg) that triggers both humoral and cell-mediated immune responses, enabling the body to recognize and neutralize hepatitis B virus upon exposure. This prevents infection and chronic hepatitis B disease development in vaccinated individuals.
Approved indications
- Prevention of hepatitis B virus infection
Common side effects
- Injection site pain or swelling
- Fever
- Fatigue
- Headache
Key clinical trials
- Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™ (PHASE3)
- Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination (PHASE3)
- A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B. (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Henogen HBV vaccine CI brief — competitive landscape report
- Henogen HBV vaccine updates RSS · CI watch RSS
- Henogen portfolio CI